THE MCLEAN HOSPITAL CORPORATION
Patent Owner
Stats
- 70 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 70 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,693 Total Citation Count
- May 31, 1985 Earliest Filing
- 95 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,337 METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPYOct 18, 17Mar 15, 18[A61K, C12N, G01N]
2017/0312,308 XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERSJul 19, 17Nov 02, 17[A61K, B82Y, A61F, A61M]
2017/0065,635 METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPYNov 16, 16Mar 09, 17[A61K]
2016/0287,100 SYSTEM AND METHOD FOR TRACKING CEREBRAL BLOOD FLOW IN FMRINov 07, 14Oct 06, 16[A61B, G01R]
2010/0041,621 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE PERFORMANCEAug 14, 09Feb 18, 10[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9855296 Methods and compositions for mitochondrial replacement therapyNov 16, 16Jan 02, 18[A61K, C12N, A01K, G01N]
9840710 Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons diseaseNov 11, 16Dec 12, 17[C07H, A61K, C12N]
9750768 Methods for purifying midbrain dopaminergic neural progenitor cellsMay 18, 12Sep 05, 17[A61K, C12N, C07K]
9737562 Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disordersDec 10, 13Aug 22, 17[A61K, A01N, B82Y, A61F, A61M]
9603872 Methods and compositions for mitochondrial replacement therapyMay 02, 08Mar 28, 17[A61K, C12N, A01K, G01N]
9517279 2-alkoxy-11-hydroxyaporphine derivatives and uses thereofApr 14, 11Dec 13, 16[A61K, C07D, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0261,165 PREVENTION AND TREATMENT OF DISEASES CHARACTERIZED BY MESENCEPHALIC DOPAMINERGIC NEURON CELL DEATHAbandonedDec 16, 11Oct 03, 13[A61K]
2013/0252,996 METHODS AND KITS FOR TREATING CLUSTER HEADACHE DISORDERSAbandonedMar 12, 13Sep 26, 13[A61K]
2013/0108,669 DOPAMINERGIC NEURONS DIFFERENTIATED FROM PLURIPOTENT STEM CELLS AND USES OF THEREOFAbandonedApr 15, 11May 02, 13[C12N]
2013/0052,268 COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASEAbandonedJun 01, 10Feb 28, 13[A61K, C12N, A61P]
2011/0301,856 METHODS AND SYSTEMS FOR DRUG SCREENING AND COMPUTATIONAL MODELING BASED ON BIOLOGICALLY REALISTIC NEURONSAbandonedMay 06, 11Dec 08, 11[G06F]
2011/0224,256 THERAPEUTIC IMPRINTING FOR THE TREATMENT OF PSYCHIATRIC DISORDERSAbandonedJun 12, 09Sep 15, 11[A61K, C07D, C07C, A61P]
2011/0218,253 IMAGING-BASED IDENTIFICATION OF A NEUROLOGICAL DISEASE OR A NEUROLOGICAL DISORDERAbandonedJan 26, 11Sep 08, 11[A61K, G06F, A61P]
2011/0208,437 METHOD AND APPARATUS FOR IDENTIFYING A SAFE AND EFFICACIOUS DOSING REGIMENAbandonedJul 31, 09Aug 25, 11[G06F]
2010/0247,564 METHODS AND COMPOSITIONS FOR THE USE OF SARGASSUM FUSIFORME FOR THE INHIBITION OF HIV-1 INFECTIONAbandonedMay 23, 08Sep 30, 10[A61K, C07C, A61P]
2010/0222,296 PYRIMIDINES, SUCH AS URIDINE, IN TREATMENTS FOR PATIENTS WITH BIPOLAR DISORDERAbandonedMay 12, 10Sep 02, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.